Results 1 to 10 of about 18,120 (154)

Drug eluting stents [PDF]

open access: yesBMJ, 2006
Last week an expert panel of the US Food and Drug Administration (FDA) recommended that the FDA should issue warnings to doctors and patients about drug eluting coronary stents. The safety of such stents is unclear except in low risk patients. Furthermore, patients with drug eluting stents should take antiplatelet therapy for at least one year after ...
Gershlick, AH, Richardson, G
  +10 more sources

Drug-eluting stents [PDF]

open access: yesCanadian Medical Association Journal, 2007
In their recent systematic review, Suzanne Ligthart and associates compared analyses of the cost-effectiveness of drug-eluting stents.[1][1] They found that in most studies in which an incremental cost-effectiveness ratio greater than $50 000 per quality-adjusted life-year was calculated the ...
E Liana, Falcone, Navdeep, Tangri
  +8 more sources

A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model

open access: yesFrontiers in Pharmacology, 2023
Introduction: Most drug-eluting stents (DESs) inhibit intimal hyperplasia but impair re-endothelialization. This study aimed to evaluate in vivo strut coverage and neointimal growth in a new glycyrrhizin acid (GA)-eluting stent.Methods: New Zealand White
Shuai Teng   +6 more
doaj   +1 more source

Comparison of Clinical Outcomes Between Second-and First-Generation Drug-Eluting Stents in Patients With Chronic Total Occlusion Lesion: A Meta-Analysis

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background and Objectives: The second-generation drug-eluting stents have been used to treat chronic total occlusion lesion. However, there is limited evidence of the clinical outcomes that whether the second-generation drug-eluting stents is superior to
Xuan Qiao   +5 more
doaj   +1 more source

Drug-eluting stent thrombosis [PDF]

open access: yesTherapeutic Advances in Cardiovascular Disease, 2009
Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS).
Stähli, B E, Camici, G G, Tanner, F C
openaire   +3 more sources

Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Results We
Scott Kinlay   +11 more
doaj   +1 more source

The role of optical coherence tomography guidance in scaffold versus stent optimization

open access: yesThe Egyptian Heart Journal, 2020
Background Optical coherence tomography showed a great ability to identify adverse features during percutaneous coronary intervention with drug-eluting stents and resulted in better clinical outcomes.
Arif A. Al Nooryani   +4 more
doaj   +1 more source

Stent thrombosis and drug-eluting stents [PDF]

open access: yesJournal of Cardiology, 2011
Coronary stents have been used for the treatment of patients with coronary artery disease (CAD), and significantly improved procedural safety and are associated with a lower rate of restenosis compared with balloon angioplasty alone. Drug-eluting stents (DES) have been dominant for the treatment of CAD with efficacy in significantly reducing both ...
Takayama, Tadateru   +2 more
openaire   +2 more sources

An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease

open access: yesBalkan Medical Journal, 2019
Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik   +2 more
doaj   +1 more source

Drug eluting coronary stents

open access: yesBMJ, 2002
Percutaneous coronary revascularisation has revolutionised the treatment of ischaemic heart disease during the past two decades. Despite technical refinements, however, long term results after using standard techniques remain limited by the phenomenon of restenosis—a process whereby elastic recoil and neointimal hyperplasia occur at the site of ...
N P, Jenkins   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy